Superparamagnetic agents in magnetic resonance imaging: Physicochemical characteristics and clinical applications. A review

Journal of Drug Targeting

Volumn 6, Issue 3, 1998, Pages 167-174

  Bonnemain, Bruno ^a  

^a Laboratoire Guerbet   (France)

Author keywords

Contrast agent; Iron oxide; Magnetic resonance imaging; Superparamagnetism

Indexed keywords

CONTRAST MEDIUM; IRON OXIDE; NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

BRAIN ISCHEMIA; DIAGNOSTIC IMAGING; GASTROINTESTINAL TRACT; HEART MUSCLE ISCHEMIA; LIVER; LYMPH NODE; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PERFUSION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SPLEEN;

EID: 0032426610     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869808997890     Document Type: Review

References (50)

1. Anzai, Y., Mclachlan, S., Morris, M. et al., Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck, AJNR, 1994, 15(1): 87-94.
2. Bach-Gansmo, T., Dupas, B., Gayet Delacroix, M. et al., Abdominal MRI using a negative contrast agent, British Journal of Radiology, 1993, 66(785): 420-425.
3. Bellin, M.F., Zaim, S., Auberton, E. et al., Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR Imaging, Radiology, 1994, 193: 657-663.
4. Bonnemain, B., Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation for potential appications, in: Contrast Media Research (CMR), Naantali 17-22, juin 1995, p. 35.
5. Bruel, J.M., Superparamagnetic iron oxide for the detection of hepatic lesions with MR Imaging results of a phase III trial, Radiology: RSNA, 1993, 189(977) (suppl.), p. 273.
6. Canet, E., Revel, D., Forrat, R. et al., Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI, Magnetic Resonance Imaging, 1993, 11(8): 1139-1145.
7. Chambon, C., Clement, O., Le Blanche, A. et al., Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence, Magnetic Resonance Imaging, 1993, 11(4): 509-519.
8. Daldrup, H.E., Reimer, P., Rummeny, E.J. et al., New superparamagnetic iron particles for MRI. Phase II study of malignant liver tumors, Radiologe, 1995, 35(8): 486-493.
9. Dormann, J.L., Superparamagnetism phenomenon, Rev. Phys. Appl., 1981, 16(6): 275-301.
10. Engelstad, B. and Wolf, G., Contrast Agents, in: Magnetic Resonance Imaging (eds.) Stark, D. and Bradley, W., 1988, The C.V. Mosby Company, St. Louis, USA.
11. Engelhard, H. and Petruska, D., Imaging and movement of iron-oxide-bound antibody microparticles in brain and cerebrospinal fluid, Cancer Biochem. Biophys., 1992, 13: 1-12.
12. Enochs, W., Schaffer, B., Bhide, P. et al., MR Imaging of slow axonal transport in vivo, Experimental neurology, 1993, 123: 235-242.
13. Franck, H., Weissleder, R. and Brady, T.J., Enhancement of MR Angiography with iron oxide: preliminary studies in whole-blood phantom and in animals, AJR, 1994, 162: 209-213.
14. Hahn, P.F., Stark, D.D., Lewis, J. et al., First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR Imaging, Radiology, 1990, 175: 695-700.
15. Haldemann-Heusler, R.C., Wight, E. and Marincek, B., Oral superparamagnetic contrast agent (ferumoxsil): tolerance and efficacy in MR Imaging of gynecologic diseases, JMRI, 1995, 4: 385-391.
16. Hamm, B., Staks, T. and Taupitz, M., A new superparamagnetic iron oxide contrast agent for Magnetic Resonance Imaging Investigative Radiology, 1994, 29 (suppl. 2), S87-89.
17. Jung, C.W. and Jacobs, P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil, Magnetic Resonance Imaging, 1995, 13(5): 661-674.
18. Josephson, L., Groman, E.V., Menz, E. et al., A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent, Magnetic Resonance Imaging, 1990, 8: 637-646.
19. Klaveness, J., Particulate agents, in: Enhanced MRI - Runge VM - The C.V. Mosby Company, St Louis, 1989, pp. 117-128.
20. Krieg, F., Andres, R. and Winterhalter, K., Superparamagnetically labelled neutrophils as potential abscess-specific contrast aaent for MRI, Magnetic Resonance Imaging, 1995, 13(3), 393-400.
21. Lauterbur, P.C., Spatially-resolved studies of whole tissues, organs and organisms by NMR zeugmatography, in: NMR Biol., [Proc. Br. Biophys. Soc. Spring Meet.] (eds.) Dwek, R.A., Campbell, I.D. and Richards, R.E., 1997, Academic Publishers, London, England, pp. 323-335.
22. Mac Vicar, D., Jacobsen, T.F., Guy, R. et al., Phase III trial of oral magnetic particles in MRI of abdomen and pelvis, Clinical Radiology, 1993, 47(3): 183-188.
23. Mergo, P., Helmberger, T., Nicolas, A. et al., Ring enhancement in ultrasmall superparamagnetic iron oxide MR Imaging: a potential new sign for characterization of liver lesions, AJR, 1996, 166: 379-384.
24. Muller, R.N. and Roch, A., in: 11th annual scientific meeting; SMRM; works in progress; Berlin 8-14, Août 1992, p. 1447.
25. Petropoulos, A., Schaffer, B., Cheney, M. et al., MR Imaging of neuronal transport in the guinea pig facial nerve: initial findings, Acta Otolaryngol (Stockh), 1995, 115: 512-516.
26. Pouliquen, D., Lucet, I., Chouly, C. et al., Liver-directed superparamagnetic iron oxide: quantitation of T2 relaxation effects, Magnetic Resonance Imaging, 1993, 11(2): 219-228.
27. Reith, W., Forsting, M., Vogler, H. et al., Early MR detection of experimentally induced cerebral ischemia using magnetic susceptibility contrast agents: comparison between gadopentetate dimeglumine and iron oxide particles, AJNR 1995, 16: 53-60.
28. Renshaw, P.F. et al., Ferromagnetic contrast agents: a new approach, Magn. Res. Med., 1986, 3: 217.
29. Riehm, S., Veillon, F., Linguenheld, C. et al., Superparamagnetic iron oxide (SPIO) enhanced MRI compared with spiral CT: an experience of 28 biopsied benign and malignant tumors of the liver, Rev. Im. Med., 1994, 6(10), S343,
30. in: European Congress of Radiology (ECR); Vienne 5-10 mars 1995, p. S317, n. 1063.
31. Rogers, J.M., Lewis, J. and Josephson, L., Visualization of superior mesenteric lymph nodes by the combined oral and intravenous administration of the ultrasmall superparamagnetic iron oxide, AMI-227, Magnetic Resonance Imaging, 1994, 12(8): 1161-1165.
32. Ros, P.R., Freeny, P.C., Harms, S.E. et al., Hepatic MR Imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions, Radiology 1995, 195: 481-488.
33. Rubin, D.L., Muller, H.H., Young, S.W., Hunke, W.A., German, W.G. and Lee, K.C., Investigative Radiol., 1995, 30(4): 226-231.
34. Seneterre, E., Gallix, B., Taourel, P. et al., Tissue characterization with superparamagnetic iron oxide: signal intensity changes of hepatic nodules. Tissue characterization: signal intensity changes and morphological features of hepatic nodules with superparamagnetic iron oxide (spio). In: 5th annual meeting; abdominal imaging and intervention (ESGR); abstract book; Taormina, 1-4 juin 1994, 107,
35. in: European Congress of Radiology (ECR); Vienne 5-10 mars 1995a, p. S281 n. 1406.
36. Seneterre, E., Bouvier, Y., Vergnes, C. et al., CT arterial portography (CTAP) versus superparamagnetic iron oxide (spio) enhanced MR Imaging for screening of hepatic metastases. Comparaison du portoscanner et de I'IRM après ENDOREM dans la détection des métastases hépatiques: étude par courbes ROC avec échogrpahie per opératoire pour gold standard, Radiol. (JFR), 1995b, 76(10): 755.
37. Stark, D.D., Saini, S., Hahn, P.F. et al., Ferrite: a superparamagnetic contrast agent for MR Imaging, Magnetic Resonance Imaging, 1987, 5 (suppl. 1), 99-100.
38. Storm, B.L., Abbitt, P.L., Allen, D.A. et al., Splenosis: superparamagnetic iron oxide-enhanced MR Imaging, AJR, 1992, 159: 333-335.
39. Suto, Y., Kato, T., Matsuo, T. et al., Chondroitin sulfate iron colloid as MR contrast agent in differentiation between hepatocellular carcinoma and adenomatous hyperplasia, Acta Radiologica, 34, 1993, Fasc. 3, 226-229.
40. Tifenauer, L., Kühne, G. and Andres, R., Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor specific contrast agent for Magnetic Resonance Imaging, Bioconjugate Chem., 1993, 4: 347-352.
41. Torres, G.M., Erquiaga, E., Ros, P.R. et al., Preliminary results of MR Imaging with superparamagnetic iron oxide in pancreatic and retroperitoneal disorders, Radiographics, 1991, 11: 785-791.
42. Trillaud, H., Degreze, P., Combe, C. et al., USPIO-enhanced MR Imaging of glycerol-induced acute renal failure in the rabbit, Magnetic Resonance Imaging, 1995, 13(2): 233-240.
43. Vlahos, L., Gouliamos, A., Athanasolpoulou, G. et al., A comparative study between Gd-DTPA and oral magnetic particles (OMP) as gastrointestinal (GI) contrast agents for MRI of the abdomen, Magnetic Resonance Imaging, 1994a, 12(5): 719-26.
44. Vlahos, L., Gouliamos, A., Kalovidouris, A. et al., Oral magnetic particles as a contrast agent for MR Imaging of the abdomen. A phase III clinical trial, Hepato-Gastroenterology, 1994b, 41(1): 82-85.
45. Vogl, T., Hammerstingl, R., Pegios, W. et al., Wertigkeit des leberspezifischen superparamagnetischen kontrastmittels ami-25 fur die detektion und differential-diagnose lebereigener tumoren versus metastasen, ROFO, 1994, 160(4): 319-328.
46. Weissleder, R., Stark, D.D., Bacon, B.R. et al., Ferrite particles: evidence for biodegradability and safety as a tissue-specific contrast agent for MR Imaging, Radiology: RSNA, 1987, 165 (suppl. P), p. 354, poster 8.
47. Weissleder, R., Lee, A., An Khaw, B. et al., Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody Imaging, Radiology, 1992, 182: 381-385.
48. Weissleder, R., Heautot, J.F., Schaffer, B.K. et al., MR lymphography: study of a high-efficiency lymphotropic agent, Radiology, 1994, 191(1): 225-230.
49. Wisner, E., Amparo, E., Vera, D. et al., Arabinogalactan-coated superparamagnetic iron oxide: effect of particle size in liver MRI, Journal of Computer Assisted Tomography, 1995, 19(2): 211-215.
50. Zimmer, C., Weissleder, R., O'Connor, D. et al., Cerebral iron oxide distribution: in vivo mapping with RM Imaging, Radiology, 1995, 196: 521-527.